Ethyl 2-((tert-butoxycarbonyl)amino)-2-(pyridin-4-yl)acetate, 97%, 250mg

4-Cyanobenzoyl Chloride>98.0%(GC)(T)25g

N,N'-(2-Chloro-1,4-phenylene)diacetamide, 95.0%, 1g

tert-Butyl 3-(aminomethyl)morpholine-4-carboxylate hydrochloride, 95.0%, 250mg

Hexanoic Anhydride, >96.0%(GC), 25g

(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-phenoxytetrahydro-2H-pyran-3,4,5-triol, 95.0%, 5g

N,N'-Bis(2-ethylhexyl)-3,4,9,10-perylenetetracarboxylic Diimide>98.0%(HPLC)(N)200mg

Methyl 4-chloro-2-formylbenzoate, 97%, 5g

Trinonylamine>98.0%(T)5mL

Methyl 6-(Hydroxymethyl)nicotinate, 97.0%, 5g

Methyl 3-amino-1-benzylpyrrolidine-3-carboxylate, 95.0%, 100mg

GC capillary column ROTI®Cap-5, 30 m, 0.32 mm, 1.00 µm, 1 Piece(s)

4,4,4-Trifluoro-1-(2-naphthyl)-1,3-butanedione>98.0%(GC)5g